Equity compensation at a private company is one of the most financially complex components of your financial life. Done right, it can accelerate your path to financial independence by years. Done poorly, it can cost you six figures in unnecessary taxes, or leave you holding worthless shares you paid real money to own.
I’ve worked through equity compensation decisions with dozens of clients. Early-stage startup employees, late-stage pre-IPO professionals, and everyone in between. And what I’ve found is that the people who handle it best aren’t necessarily the ones who know the most. They’re the ones who have a framework for making decisions under uncertainty, and who understand the rules of the game before they’re forced to play.
The challenge is that private company equity isn’t like a paycheck or a bonus. There’s no single right answer. The decisions you need to make depend on your specific situation, your financial goals, and how much risk you can actually afford to take on.
This guide walks you through everything you need to know: the types of equity you’re likely to receive, the key decisions at each stage, the tax traps to avoid, and the planning frameworks I use with clients every day.
What types of equity compensation do private companies offer?
Before getting into strategy, it helps to understand the landscape. Private companies typically grant equity in four main forms, and which type you receive often depends on how early you joined the company and how far along it is in its funding journey.
One of the first things I do with a new client who has private company equity is pull up their actual grant documents. More often than not, they aren’t sure what type of equity they hold. Knowing the difference matters enormously because the tax treatment and planning decisions are completely different depending on what you have.
Restricted Stock is most common at the very earliest stage, when the company’s 409A valuation is near zero. You’re granted actual shares outright, subject to vesting requirements before they’re truly yours.
Incentive Stock Options (ISOs) give you the right to purchase company stock at a set price in the future. ISOs carry preferential tax treatment with no ordinary income tax at exercise, but come with AMT exposure and specific holding period requirements to keep those benefits.
Non-Qualified Stock Options (NSOs) work similarly to ISOs but without the favorable tax treatment. When you exercise NSOs, you owe ordinary income tax on the spread between the exercise price and the current fair market value. NSOs can be granted to employees, advisors, and consultants alike.
Restricted Stock Units (RSUs) are a promise to grant you shares when certain conditions are met. At private companies, RSUs typically have “double trigger” vesting, meaning you need both a service requirement and a liquidity event before they vest. This protects you from owing taxes on shares you can’t yet sell.
What is a 409A valuation and why does it matter?
A 409A valuation is an independent appraisal of your company’s fair market value per share, typically updated annually or after significant fundraising rounds. It matters for your equity planning because it sets the exercise price for new option grants, determines your taxable income when you exercise NSOs or when RSUs vest, calculates the “bargain element” that triggers AMT when you exercise ISOs, and is used to assess QSBS eligibility.
One thing clients consistently struggle with is the disconnect between the 409A valuation and what they believe their shares are actually worth. I think of private company equity like a tailwind. It’s not the engine of your financial plan. It’s something that can make you go faster. But until a liquidity event occurs, it’s paper wealth, and your financial plan needs to treat it that way. That means building everything else on the foundation of your actual salary and liquid assets, not on equity you can’t yet access.
As the company grows through new funding rounds, the 409A valuation typically increases, sometimes dramatically. This is why exercising early when the spread is small can be a smart move.
What is an 83(b) election and should I make one?
The 83(b) election is, in my experience, one of the most misunderstood and most consequential decisions in early-stage equity planning. I’ve walked through it with 15-20 client households, and without exception, every single one needed explanation. They either didn’t know what it was, didn’t understand the 30-day deadline, or didn’t fully grasp the risk they were accepting.
The 83(b) election is a one-time IRS election that allows you to pay tax on restricted stock now, based on its current value, rather than waiting until vesting. Once you make the election, any future appreciation is taxed as a capital gain instead of ordinary income, which typically means a much lower rate.
When it makes sense: If you’ve been granted Restricted Stock when the company’s 409A is near zero, making an 83(b) election costs you nothing in taxes today and converts all future appreciation to capital gain treatment. It’s often a no-brainer. And if your shares qualify as QSBS (more on this below), filing the 83(b) also starts your five-year holding period clock earlier, which can be worth hundreds of thousands of dollars at exit. The 83(b) and QSBS together are the most powerful one-two punch in early-stage equity planning.
When to be careful: If the Restricted Stock has meaningful value at grant, you’ll owe taxes now on shares you don’t fully own yet. If you leave before the shares vest, you don’t get that tax back. I’ve had clients sit with the very real fear that they’re paying taxes on something that might never pay off. That fear is legitimate. The decision requires weighing your conviction in the company against the cost of paying an early tax on something uncertain.
The hard deadline: You have exactly 30 days from the grant date to file the 83(b) election with the IRS. I’ve seen situations where this window was almost missed, and in each case the client would never have caught it on their own. Put it on your calendar the day you receive the grant.
One important note: you cannot make an 83(b) election on RSUs. For early-exercised ISOs, the 83(b) election affects AMT treatment, not regular tax treatment — the full ISO mechanics still apply. For Restricted Stock and early-exercised NSOs, the 83(b) does convert future appreciation to capital gain treatment.
When should I exercise my stock options at a private company?
“When should I exercise, and how much?” is probably the question I hear most often from clients with private company equity. It comes up in nearly every engagement. When I sit down with a client to work through this, I frame it as three options.
Option A: Do nothing. Keep your ISOs unexercised. If there’s an IPO or you leave, do a cashless exercise at that point. The problem is that any gain gets taxed at ordinary income rates. For many of my clients in high-income years, that’s in the range of 45% combined federal and state, though your actual rate depends on your income and state. That’s the default path if you don’t make a deliberate choice.
Option B: Exercise everything now. Pay cash to exercise your full option grant, hold the shares for the required period, and eventually sell at long-term capital gains rates, which for many clients runs around 25% combined, though again this is situational. The downside is a large cash outlay, significant AMT exposure, and real risk that the shares end up worthless.
Option C: The middle ground. Exercise just enough ISOs each year to stay below the AMT threshold or purposefully triggering AMT in a way that comfortably fits with your cash flow. Hedge your bet. This is what I recommend most often. It’s not exercising everything, but there’s an amount where you can build your holding period and basis without triggering AMT. Think of it as the Goldilocks approach: not too much, not too little, tuned to your specific situation each year.
Option C is a multi-year strategy, not a one-time decision. The goal is systematic progress, a little bit along the way, rather than being forced into a large exercise at a moment that may not be tax-optimal.
The risk you’re accepting with any exercise: Private company stock has no liquid market. When you exercise, you’re paying real cash for shares you may not be able to sell for years. The right mindset is to exercise with the understanding that you might never see that money again. Ask yourself: how would my financial life change if I exercised and the company never had a liquidation event? If the answer is “I’d be fine,” exercising may make sense. If the answer is “I’d really feel that loss,” slow down.
What is AMT and how does it affect ISO exercises?
AMT is the single most anxiety-inducing tax concept in private company equity planning. I’ve had this conversation with at least 15 client households, and the reaction is almost always the same: disbelief that you could owe a meaningful tax bill on shares you haven’t sold and can’t sell.
Here’s how to think about it. The federal government runs two parallel tax calculations every year, your regular income tax and your AMT. You pay whichever is higher. When you exercise ISOs, the “bargain element” (the spread between the 409A value at exercise and your exercise price, multiplied by shares exercised) gets added to your AMT calculation but not your regular income tax. If that pushes your AMT above your regular tax, you owe the difference in cash, this year, on shares you can’t sell.
This is where people have gotten into serious trouble. If you haven’t been exercising incrementally and you’re suddenly forced to exercise a large block because you’re leaving the company or a liquidity event is imminent, you can end up with a six-figure AMT bill and no liquid shares to cover it. That’s the nightmare scenario. I use it as a cautionary example not to scare clients, but to illustrate exactly why doing a little bit along the way protects you from being forced into a terrible situation later.
The AMT cushion: Each year, I work with clients and their CPAs to calculate exactly how many ISOs they can exercise before their AMT calculation exceeds their regular income tax. That number is the cushion. Exercise up to it, stop there, and repeat the analysis next year as valuations and income change. One nuance worth knowing: California’s AMT credit is harder to recapture than the federal credit, so for California-based clients, staying below the California AMT threshold is especially important.
It’s also worth understanding that even when you exercise within the cushion and owe no net AMT, ISO shares carry a dual basis — a regular tax basis and a separate AMT basis. These can differ, and tracking both matters for future dispositions. This is an area where a CPA who understands equity comp is not optional.
AMT credits: If you do pay AMT in a year you exercise ISOs, you generate a credit on IRS Form 8801 that can offset future regular tax liability. These credits are real and valuable, but they’re frequently lost when people switch CPAs or file their own taxes. Keep meticulous records.
What should I know about NSOs at private companies?
When you exercise NSOs, the spread between the fair market value and your exercise price is taxed as ordinary income immediately. You need cash not just for the exercise price but also for the resulting tax bill. For high-income earners in California, that combined rate can approach 50% on the spread.
If you have both ISOs and NSOs, ISOs often present more tax leverage because of capital gains treatment and QSBS eligibility. That said, this isn’t absolute. There are situations where exercising NSOs in a lower-income year makes sense, where AMT risk on ISOs is too high relative to the potential upside, or where a client simply can’t afford the AMT exposure. It requires modeling, not a blanket rule. Generally speaking though, if you’re going to deploy cash toward exercising anything, ISOs are worth thinking about first.
What is QSBS and could my equity qualify?
Qualified Small Business Stock is one of the most powerful and most underutilized tax provisions in private company equity planning. I have QSBS referenced in the planning notes of 15-20 client households, and in nearly every case, the potential tax savings justify making it a central part of the strategy.
Under Section 1202 of the tax code, you may be able to exclude up to 100% of your capital gains from federal tax when you sell QSBS. The exclusion limits and holding period requirements depend on when the stock was issued, as covered in the eligibility section below.
Basic eligibility requirements:
- Domestic C-corporation
- Gross assets under $50 million at issuance for stock issued on or before July 4, 2025; under $75 million for stock issued after that date
- Acquired directly from the company, not on the secondary market
- Eligible industry (most tech and software companies qualify)
- Held for the required period: for pre-July 4, 2025 stock, more than five years for 100% exclusion; for stock issued after July 4, 2025, partial exclusions are available at three years (50%) and four years (75%), with full exclusion at five years
The per-issuer gain exclusion cap is the greater of $10 million or 10x your adjusted basis for stock issued on or before July 4, 2025, and the greater of $15 million or 10x basis for stock issued after that date.
One important caveat for California residents: California does not conform to the federal QSBS exclusion. Even if your gain is fully excluded at the federal level, it may still be taxable at the state level. This doesn’t eliminate the benefit, but it’s a meaningful planning consideration that most people don’t know until it’s too late.
The 83(b) and QSBS intersection: For stock options, the QSBS five-year holding period starts when you exercise, not when shares vest. So early-exercising starts that clock immediately rather than waiting for each tranche to vest over time. One important nuance for ISOs specifically: the 83(b) election on early-exercised ISOs affects the AMT calculation, not the regular tax treatment. ISOs are dual-basis stock, meaning you have a regular tax basis and a separate AMT basis, and the interaction between them is something your CPA needs to track carefully. The simplification that “83(b) converts everything to capital gains” is true for NSOs and Restricted Stock, but for ISOs it’s more accurate to say the 83(b) affects AMT timing. What all of this means practically: early exercise gets your QSBS clock started sooner, and proper planning around the 83(b) and AMT basis can be worth an enormous amount at exit. But the mechanics are complex enough that this is not a do-it-yourself area.
The tender offer caution: If a tender offer comes before you’ve crossed the five-year holding period, selling those shares forfeits the QSBS exclusion entirely. This is one of the most important inputs in any tender offer decision, and I walk clients through it explicitly before they decide whether to participate.
What happens to my stock options if I leave the company?
“What happens to my equity if I leave?” is one of the most common questions I hear, and one most people don’t think to ask until they’re already facing the decision.
Most stock agreements give you 90 days post-termination to exercise vested options. After that window closes, you lose them permanently. Ninety days sounds like a lot. It isn’t, especially when you’re figuring out cash flow, negotiating a new role, and managing the emotional weight of a job transition at the same time. One additional wrinkle: ISOs that aren’t exercised within 90 days of termination convert to NSOs, which means you lose the preferential ISO tax treatment even if you do eventually exercise. The clock matters more than most people realize.
I’ve seen this play out in a few distinct ways.
One client was planning a sabbatical and needed to map out exactly what would happen to their equity if the leave extended into a departure. We worked through which grants would continue vesting during approved leave, which wouldn’t, and what the exercise deadlines looked like under each scenario. That planning also turned into an unexpected opportunity. A lower-income year during the sabbatical created a larger AMT cushion, making it an ideal moment to accelerate ISO exercises. The sabbatical wasn’t just a career pause. It became a preview of what financial independence would actually feel like.
Another client faced an unexpected job loss at a startup running low on runway. We had to quickly evaluate whether exercising vested options made sense given the company’s uncertain future, the cash required, and whether QSBS eligibility changed the calculus. There’s no clean answer in that situation. It comes down to risk tolerance and what you can genuinely afford to lose.
Some companies offer post-termination windows beyond 90 days. If your company doesn’t, it may be worth asking, especially if you’re a senior employee. An extended window fundamentally changes the exercise decision.
Before you resign from any company with meaningful vested equity: do the full analysis before you give notice. Know your vested option count, the exercise cost, the tax implications, and whether you have the cash and risk appetite to act. Leaving without this analysis is one of the most avoidable and costly mistakes I see.
What is a tender offer and should I participate?
Tender offers are one of the most nuanced decisions in private company equity planning. I’ve worked through them with multiple client households, and the emotional complexity is just as real as the financial complexity.
A tender offer is a structured opportunity to sell some of your private company shares to a third-party institutional buyer before a formal IPO or acquisition. They’re becoming increasingly common as companies stay private longer.
Here’s the framework I use:
Price vs. 409A. A significant premium to the 409A signals the market values the company above its last internal appraisal. That context matters.
Tax implications. Whether you’re selling previously exercised shares or exercising and selling simultaneously determines whether your gain is ordinary income or capital gain. Holding period is everything.
QSBS impact. Selling before the five-year holding period forfeits the exclusion on those specific shares. I flag this explicitly in every tender offer analysis.
Concentration risk. If your financial life is heavily concentrated in one company through salary, unvested equity, and already-exercised shares, taking some liquidity off the table is worth serious consideration even if you believe in the upside. You’re already long this company in more ways than one.
Liquidity vs. upside. The tender offer gives you certainty at a known price. Waiting gives you uncertainty at an unknown price, which could be higher, lower, or zero. Neither outcome is predictable, and that’s exactly the point.
In one situation, a client was eligible to sell roughly 7,300 shares at approximately $94/share, around $683K gross minus exercise costs. The recommendation was to participate and take meaningful liquidity. The math was clear, but the harder conversation was separating conviction about the company’s future from the real value of liquidity today.
One other thing worth saying: not everyone is happy with tender offer pricing. Sometimes employees feel the offered price undervalues what the company is worth, that the institutional buyer is getting too good a deal. That frustration is understandable. But it requires separating two distinct questions: what do you believe this company will be worth eventually, and what is certain liquid cash worth to you today? Conflating them tends to lead to decisions people regret.
Tax planning strategies for private company equity compensation
The difference between thoughtful tax planning and reactive decision-making is easily six figures over the lifecycle of a liquidity event. These are the strategies I build into client planning on a recurring basis.
Annual AMT cushion analysis. Every year, I work with clients and their CPAs to calculate the exact number of ISOs they can exercise before crossing into AMT territory. Exercise up to that number, stop there, and repeat the analysis next year. This is the core of Option C.
Spreading exercises across tax years. Rather than exercising a large block at once, spreading across multiple years manages AMT exposure and ordinary income simultaneously. This requires multi-year modeling, not just a snapshot of this year’s return.
Timing exercises around income events. Lower-income years, whether from a sabbatical, job transition, or a year when bonuses are down, often create a larger AMT cushion and are ideal windows for accelerating exercises. I’ve seen clients turn a planned career pause into a meaningful equity planning opportunity.
Using equity proceeds intentionally. When liquidity arrives from a tender offer, RSU sales, or an exit, the question isn’t just where does this go in the portfolio. It’s what does this make possible? I use a simple three-bucket framework: a stability layer of cash for 0-3 years of needs, a flexibility layer in a taxable brokerage account for things like home renovations or a sabbatical (3-15 years), and a long-term growth layer in retirement accounts (15+ years). Equity proceeds typically flow into the flexibility or long-term bucket depending on the timeline, and sometimes they fund specific life goals directly. Think of it as turning up the dial on the things that actually matter to you.
Charitable giving with appreciated shares. Donating shares to a donor-advised fund before a liquidity event lets you deduct the full fair market value while avoiding capital gain entirely. A meaningful strategy in the year of a large exit.
Estimated tax payments. If you exercise NSOs or have RSUs vest in large amounts, your employer likely won’t withhold enough. Work with your CPA to model quarterly payments well before year-end.
Key questions to ask about your private company equity
Before making any decisions, make sure you can answer these.
What type of equity do I have? Pull your grant documents. Don’t assume. I’ve seen clients who thought they had ISOs discover they had NSOs, and vice versa.
What is my current 409A valuation and exercise price? The spread between these two numbers determines your tax exposure at exercise.
When does my equity vest? Know your full schedule, including cliff dates and any acceleration provisions in a sale.
Does my equity qualify as QSBS? Ask your company’s legal team and get it in writing.
What is my post-termination exercise window? Know this before you’re facing a job change, not after.
Does my company have a secondary market or tender offer program? Worth asking, especially at later-stage companies.
Have I modeled the AMT implications of exercising? Don’t exercise ISOs without this analysis. There’s no undoing a surprise AMT bill on illiquid shares.
Why equity compensation planning is inseparable from life planning
Here’s the thing about private company equity: the financial analysis is only half of it. The other half is understanding what this equity actually means to you and what it’s supposed to do for your life.
For most of my clients, it represents a specific possibility. The potential to reach financial independence sooner. To have real options about how and where they work. To build a foundation strong enough that work becomes a choice rather than a requirement. At a certain point, you’re playing with house money, and every year that equity grows, the next chapter gets a little more on your terms.
That’s why “I don’t want to make the wrong call and regret it” is such a common thing to hear in these conversations. The fear of regret is real because the stakes are real. But there’s no decision that eliminates uncertainty here. What good planning does is make sure you understand the tradeoffs clearly, that the decision you make is consistent with your actual financial life, and that you’re not letting anxiety drive you toward inaction. With ISOs especially, doing nothing is often the riskiest option of all.
If your equity is starting to feel like golden handcuffs, keeping you at a job longer than you’d otherwise stay, that’s worth examining honestly. The financial cost of leaving is real. So is the cost of staying somewhere that no longer fits. What I try to do is make sure you know exactly what those costs are, so the decision is actually yours to make.
Working with a financial planner on your equity compensation
Private company equity compensation is one of the most interconnected areas of financial planning. AMT in one year affects QSBS holding periods. QSBS holding periods affect tender offer decisions. Tender offer decisions affect concentration risk. All of it folds into whether your equity actually gets you to financial independence on the timeline you’re hoping for.
Getting it right requires more than knowing the rules. It requires someone who can model your specific situation year over year, coordinate with your CPA, and help you make decisions you feel genuinely confident in, not just technically correct ones.
At Experience Your Wealth, we specialize in helping high-income professionals navigate the full lifecycle of equity compensation, from understanding your grant documents in year one to building an annual exercise strategy to preparing for a liquidity event that could meaningfully change your financial life.
If you’re sitting on private company equity and aren’t sure what decisions you should be making, or you’ve been making decisions without a clear plan, we’d be glad to help you get clear on where you stand.
Schedule a free introductory meeting here.
Experience Your Wealth is a fee-only, fiduciary financial planning firm for high-income professionals with equity compensation, business ownership, or significant wealth. We help you define what “enough” actually looks like for you, then build an integrated strategy around your income, equity, tax, and investments to help you get there. No products. No AUM fees. Just a strategic partner who helps you use your wealth to amplify the life you actually want. We work virtually with clients across the country.
Disclosures: None of the information provided is intended as investment, tax, accounting or legal advice, as an offer or solicitation of an offer to buy or sell, or as an endorsement of any company, security, fund, or other securities or non-securities offering. The information should not be relied upon for purposes of transacting securities or other investments. Your use of the information is at your sole risk.
Jake Northrup, CFP® is the founder of Experience Your Wealth, a fee-only financial planning firm specializing in equity compensation, financial independence, and life-centered planning for high-income professionals.